NRAS and melanoma: Similar results were obtained in other BRAFV600E-positive melanoma cells such as G361 and SK-MEL-5, but not in MeWo and NRAS mutant SK-MEL-2 cells that contain WT BRAF (Supplementary Fig. 2a–d).